Abstract
Fatty acids are metabolized in the liver by β-oxidation in mitochondria and peroxisomes and by ω-oxidation in microsomes. Peroxisomal β-oxidation is responsible for the metabolism of very long chain fatty acids and mitochondrial β-oxidation is responsible for the oxidation of short, medium and long chain fatty acids. Very long chain fatty acids are also metabolized by the cytochrome P450 CYP4A ω-oxidation system to dicarboxylic acids. Both peroxisomal ω-oxidation and microsomal β- oxidation lead to the generation of H2O2. The genes encoding peroxisomal, microsomal and some mitochondrial fatty acid metabolizing enzymes in the liver are transcriptionally regulated by peroxisome proliferator-activated receptor α (PPARα). Sustained activation of PPARα by peroxisome proliferators has been shown to induce hepatocellular carcinomas in rats and mice. The peroxisome proliferator-induced carcinogenic effect has been attributed to transcriptional activation of PPARα regulated genes and the resulting excessive generation of H2O2. Evidence from mice lacking fatty acyl-CoA oxidase (AOX), PPARα and PPARα / AOX has confirmed the role of PPARα in the development of hepatocellular carcinomas. In addition, mice lacking AOX developed steatohepatitis and provided clues regarding the molecular mechanism responsible for steatosis and steatohepatitis and the role of unmetabolized AOX substrates in the activation of PPARα.
Keywords: peroxisome proliferator, activated receptors, steatohepatitis, acyl-coa oxidase, oxidation system, hepatocarcinogenesis
Current Molecular Medicine
Title: Peroxisome Proliferator-Activated Receptors, Fatty Acid Oxidation, Steatohepatitis and Hepatocarcinogenesis
Volume: 3 Issue: 6
Author(s): Songtao Yu, Sambasiva Rao and Janardan K. Reddy
Affiliation:
Keywords: peroxisome proliferator, activated receptors, steatohepatitis, acyl-coa oxidase, oxidation system, hepatocarcinogenesis
Abstract: Fatty acids are metabolized in the liver by β-oxidation in mitochondria and peroxisomes and by ω-oxidation in microsomes. Peroxisomal β-oxidation is responsible for the metabolism of very long chain fatty acids and mitochondrial β-oxidation is responsible for the oxidation of short, medium and long chain fatty acids. Very long chain fatty acids are also metabolized by the cytochrome P450 CYP4A ω-oxidation system to dicarboxylic acids. Both peroxisomal ω-oxidation and microsomal β- oxidation lead to the generation of H2O2. The genes encoding peroxisomal, microsomal and some mitochondrial fatty acid metabolizing enzymes in the liver are transcriptionally regulated by peroxisome proliferator-activated receptor α (PPARα). Sustained activation of PPARα by peroxisome proliferators has been shown to induce hepatocellular carcinomas in rats and mice. The peroxisome proliferator-induced carcinogenic effect has been attributed to transcriptional activation of PPARα regulated genes and the resulting excessive generation of H2O2. Evidence from mice lacking fatty acyl-CoA oxidase (AOX), PPARα and PPARα / AOX has confirmed the role of PPARα in the development of hepatocellular carcinomas. In addition, mice lacking AOX developed steatohepatitis and provided clues regarding the molecular mechanism responsible for steatosis and steatohepatitis and the role of unmetabolized AOX substrates in the activation of PPARα.
Export Options
About this article
Cite this article as:
Yu Songtao, Rao Sambasiva and Reddy K. Janardan, Peroxisome Proliferator-Activated Receptors, Fatty Acid Oxidation, Steatohepatitis and Hepatocarcinogenesis, Current Molecular Medicine 2003; 3 (6) . https://dx.doi.org/10.2174/1566524033479537
DOI https://dx.doi.org/10.2174/1566524033479537 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
Call for Papers in Thematic Issues
Molecular and Cellular Mechanisms in Vertigo / Vestibular Disorders
Vertigo and vestibular diseases are common among middle-aged and older adults, significantly increasing the risk of falls and leading to injuries and disabilities. Despite their prevalence, therapeutic advancements are hindered by a limited understanding of the underlying molecular and cellular mechanisms. This Special Issue is dedicated to bridging this gap ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Whole-Brain Volume CT Angiography can Effectively Detect Early Ischemic
Cerebrovascular Diseases
Current Medical Imaging Breathomics Detect the Cardiovascular Disease: Delusion or Dilution of the Metabolomic Signature
Current Cardiology Reviews Pleiotropic Effects of Glucagon-like Peptide-1 (GLP-1)-Based Therapies on Vascular Complications in Diabetes
Current Pharmaceutical Design Optimizing the Management of Uncontrolled Hypertension: What do Triple Fixed-Dose Drug Combinations Add?
Current Vascular Pharmacology Hypertension in the Neonatal Period: An Update
Current Hypertension Reviews Ezetimibe; More Than a Low Density Lipoprotein Cholesterol Lowering Drug? An Update After 4 Years
Current Vascular Pharmacology Elucidations of Molecular Mechanism and Mechanistic Effects of Environmental Toxicants in Neurological Disorders
CNS & Neurological Disorders - Drug Targets Depression and Anxiety Levels Increase Chronic Musculoskeletal Pain in Patients with Alzheimer's Disease
Current Alzheimer Research New Insight into 2-Methoxyestradiol- a Possible Physiological Link between Neurodegeneration and Cancer Cell Death
Current Medicinal Chemistry Past, Present and Future of Electroanalytical Sensor for Aspirin, Ibuprofen and Paracetamol Detection
Current Pharmaceutical Analysis The Impact of Angiotensin-Converting Enzyme Gene on Behavioral and Psychological Symptoms of Dementia in Alzheimer’s Disease
Current Alzheimer Research Quinazolines as Apoptosis Inducers and Inhibitors: A Review of Patent Literature
Recent Patents on Anti-Cancer Drug Discovery The Role of Glycoprotein IIb/IIIa Inhibitors- A Promise Not Kept?
Current Cardiology Reviews Antipyretic Medicinal Plants, Phytocompounds, and Green Nanoparticles: An Updated Review
Current Pharmaceutical Biotechnology Naringin Inhibits TNF-α Induced Oxidative Stress and Inflammatory Response in HUVECs via Nox4/NF-κ B and PI3K/Akt Pathways
Current Pharmaceutical Biotechnology Clopidogrel and Aspirin in Cardiovascular Medicine: Responders or Not -- Current Best Available Evidence
Cardiovascular & Hematological Agents in Medicinal Chemistry Biomarkers as a Guide of Medical Treatment in Cardiovascular Diseases
Current Medicinal Chemistry Takotsubo Cardiomyopathy
Current Pharmaceutical Design Pediatric Obesity Epidemic: Problem and Solutions
Current Pharmaceutical Design Endogenous Angiogenesis Inhibitors as Therapeutic Agents: Historical Perspective and Future Direction
Recent Patents on Anti-Cancer Drug Discovery